Dr. Reddy's is among the earliest global generic API manufacturers for Apixaban API and filed the USDMF in September 2015. Our customers have access to the high-quality API in customized particle sizes to facilitate formulation development.

Apixaban is an anticoagulant medication approved under the trade name Eliquis in Europe in 2011, and in the US in 2012. It was first approved to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Read the technical sheet on this topic by filling the contact form below.